As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Rockwell Medical

  • Friday's Range: $6.15-$6.71
  • 52-Week Range: $5.47-$18.90
  • Friday's Volume: 467,000
  • Three-Month Average Volume: 603,535

Rockwell Medical  (RMTI - Get Report)  operates as an integrated biopharmaceutical company in the U.S. and internationally. This stock closed up 6.2% to $6.66 in Friday's trading session.

From a technical perspective, Rockwell Medical ripped sharply higher on Friday right above some near-term support at $5.80 a share with lighter-than-average volume. This stock recently gapped-down sharply lower from around $10.50 a share to under $6.50 a share with heavy downside volume flows. Following that move, shares of Rockwell Medical have started to rebound higher off its recent low of $5.80 a share, and it's now quickly moving within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out Friday's intraday high of $6.71 a share to its gap-down-day high of $6.85 a share with high volume.

Traders should now look for long-biased trades in Rockwell Medical as long as it's trending above some near-term support levels at $6 or at $5.80 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 603,535 shares. If that breakout hits soon, then this stock will set up to re-fill some of its previous gap-down-day zone that started near $10.50 a share.

Novadaq Technologies

  • Friday's Range: $9.23-$10.00
  • 52-Week Range: $8.53-$17.29
  • Friday's Volume: 720,000
  • Three-Month Average Volume: 374,716

Novadaq Technologies  (NVDQ) , develops, manufactures and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the U.S. and internationally. This stock traded up 6.5% to $9.78 in Friday's trading session.

From a technical perspective, Novadaq Technologies ripped sharply higher on Friday right off its 20-day moving average of $9.39 a share with strong upside volume flows. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $8.99 to $9 a share. Following that potential bottom, shares of Novadaq Technologies have now started to rip higher and it's quickly trending within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $10.06 to $10.15 a share with high volume.

Traders should now look for long-biased trades in Novadaq Technologies as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 374,716 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $10.50 to its 50-day moving average of $10.80, or even $11 to its 200-day moving average of $11.52 a share.

PTC Therapeutics

  • Friday's Range: $5.69-$6.17
  • 52-Week Range: $5.29-$78.72
  • Friday's Volume: 1.48 million
  • Three-Month Average Volume: 2.13 million

PTC Therapeutics  (PTCT - Get Report) , a biopharmaceutical company, focuses on the discovery, development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. This stock traded up 6.7% to $6.15 in Friday's trading session.

From a technical perspective, PTC Therapeutics ripped sharply higher on Friday right off some near-term support at $5.62 a share with decent upside volume flows. This stock has been consolidating and trending sideways over the last few weeks, with shares moving between $5.29 on the downside and $6.80 on the upside. This spike higher on Friday is now quickly pushing shares of PTC Therapeutics within range of triggering a big breakout trade above the upper-end of its recent sideways trending chart pattern. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $6.54 to $6.80 a share with high volume.

Traders should now look for long-biased trades in PTC Therapeutics as long as it's trending above some key near-term support levels at $5.62 a share or above its new 52-week low of $5.29 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.13 million shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7.50 to $8 a share.

Walter Investment Management

  • Friday's Range: $6.60-$7.18
  • 52-Week Range: $6.31-$23.70
  • Friday's Volume: 406,000
  • Three-Month Average Volume: 339,543

Walter Investment Management  (WAC) , a diversified mortgage banking firm, focuses primarily on the servicing and origination of residential loans in the U.S. This stock traded up 4.6% to $7.14 in Friday's trading session.

From a technical perspective, Walter Investment Management spiked notably higher right off some near-term support at $6.54 a share with above-average volume. This stock has been downtrending badly over the last two months and change, with shares falling sharply off its high of $16 a share to its new 52-week low of $6.31 a share. During that downtrend, shares of Walter Investment Management have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to spike higher off that $6.31 low, and it's quickly trending within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $7.28 to its 20-day moving average of $7.46 a share and then above more resistance at $7.71 a share with high volume.

Traders should now look for long-biased trades in Walter Investment Management as long as it's trending above some near-term support at $6.54 a share or above its new 52-week low of $6.31 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 339,543 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.61 to $8.66, or even $9.64 to its 50-day moving average of $9.83 a share.

Flotek Industries

  • Friday's Range: $7.39-$8.09
  • 52-Week Range: $4.89-$21.72
  • Friday's Volume: 625,000
  • Three-Month Average Volume: 1.01 million

Flotek Industries  (FTK - Get Report)  develops and supplies oilfield products, services, and equipment to the oil, gas and mining industries in the U.S. and internationally. This stock traded up 9% to $7.93 in Friday's trading session.

From a technical perspective, Flotek Industries ripped sharply higher on Friday right off its 50-day moving average of $7.41 a share and right above its 20-day moving average of $7.20 a share with lighter-than-average volume. This stock has been uptrending strong over the last two months and change, with shares moving sharply higher off its new 52-week low of $4.89 a share to its recent high of $8.46 a share. During that uptrend, shares of Flotek Industries have been making mostly higher lows and higher highs, which is bullish technical price action. This trend to the upside on Friday is now quickly pushing this stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out Friday's intraday high of $8.09 a share to some more near-term resistance at $8.46 a share with high volume.

Traders should now look for long-biased trades in Flotek Industries as long as it's trending above its 50-day moving average of $7.41 a share or above its 20-day moving average of $7.20 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.01 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $10 to $11, or even around $12 a share.

Vitae Pharmaceuticals

  • Friday's Range: $4.56-$4.80
  • 52-Week Range: $4.15-$18.71
  • Friday's Volume: 504,000
  • Three-Month Average Volume: 342,695

Vitae Pharmaceuticals  (VTAE) , a biotechnology company, focuses on discovering and developing novel and small molecule drugs for diseases with unmet medical needs in the U.S. This stock traded up 2.3% to $4.77 in Friday's trading session.

From a technical perspective, Vitae Pharmaceuticals trended modestly higher on Friday right above some near-term support at $4.36 a share with strong upside volume flows. This stock recently gapped-down sharply lower from $11.29 a share to its new 52-week low of $4.15 a share with heavy downside volume flows. Following that move, shares of Vitae Pharmaceuticals have now started to rebound a bit off that $4.15 low, and it's quickly trending within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at Friday's intraday high of $4.80 a share to some more key resistance levels at $5.05 to its gap-down-day high of $5.33 a share with high volume.

Traders should now look for long-biased trades in Vitae Pharmaceuticals as long as it's trending above some near-term support levels at $4.36 a share or above its new 52-week low of $4.15 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 342,695 shares. If that breakout kicks off soon, then this stock will set up to re-fill some of its previous gap-down-day zone that started at $11.29 a share.

Amicus Therapeutics

  • Friday's Range: $7.33-$8.02
  • 52-Week Range: $4.99-$18.83
  • Friday's Volume: 1.96 million
  • Three-Month Average Volume: 2.36 million

Amicus Therapeutics  (FOLD - Get Report) , a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. This stock traded up 6.8% to $7.91 in Friday's trading session.

From a technical perspective, Amicus Therapeutics spiked sharply higher on Friday right above its 50-day moving average of $7 a share with decent upside volume flows. This stock has been uptrending strong over the last month and change, with shares moving higher off its new 52-week low of $4.99 a share to its recent high of $8.60 a share. During that uptrend, shares of Amicus Therapeutics have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now quickly pushed this stock within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to clear Friday's intraday high of $8.02 a share and then once it takes out some more key resistance at $8.60 a share with high volume.

Traders should now look for long-biased trades in Amicus Therapeutics as long as it's trending above its 50-day moving average of $7 a share or above its 20-day moving average of $6.96 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 2.36 million shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $10 to its 200-day moving average of $11.14, or even $11.78 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.